Position in ALXO
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$25,258
+$11,023 QoQ
Shares Held
12,598
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 68 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Abel Hall, LLC holds $10,850,864 across 52 Biotechnology names. ALXO ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,271 | $665,330 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,474 | $658,199 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,842 | $568,134 | |
| 4 | INSM |
INSMED Inc
|
3,090 | $505,276 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
7,910 | $495,957 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
4,258 | $448,793 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
1,392 | $448,488 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
8,278 | $436,416 |
All Filings in ALXO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,258 | 12,598 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $14,235 | 12,598 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,054 | 12,598 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,311 | 15,209 | Shares | Sole | 2025-07-23 | |
| 2024-12-31 | $17,378 | 10,406 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||